Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee

NCT01112722 is registered in ClinicalTrials.gov with Apimeds, Inc. as lead sponsor.

NCT NCT01112722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01112722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Lead sponsor
Apimeds, Inc.
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2013
Completion date
December 31, 2016
Enrollment
363 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis of the knee